Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AMX12006 is an antagonist of the prostaglandin E2 (PGE2) receptor subtype EP4 (IC50 = 4.3 nM).1 It is selective for EP4 over EP1, EP2, and EP3 receptors (IC50s = >10 µM for all). AMX12006 is cytotoxic to MCF-7 and 4T1 breast and CT26 colon cancer cells (IC50s = 46.73, 79.47, and 41.39 µM, respectively). It reduces tumor volume alone or in combination with the 5-fluorouracil prodrug capecitabine (Item No. 10487) in CT26 murine colon cancer models when administered at a dose of 150 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of novel, selective prostaglandin EP4 receptor antagonists with efficacy in cancer models. ACS Med. Chem. Lett. 14(6), 727-736 (2023).